Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease

References

Page 1

	Year	Citations
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Jeff Sevigny, Ping Chiao, Thierry Bussière, Nature Neurodegenerative DiseasesAlzheimer's DiseaseMedicineImmunologyDegenerative Pathology	2016	3K
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Leslie M. Shaw, Hugo Vanderstichele, Małgorzata Knapik-Czajka, Annals of Neurology	2009	2.1K
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease Lih-Fen Lue, Yu‐Min Kuo, Alex E. Roher, American Journal Of Pathology Synaptic PlasticityNeurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceSynaptic Transmission	1999	1.5K
Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians Amir Qaseem, Vincenza Snow, J. Thomas Cross, Annals of Internal Medicine	2008	346
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis Francine Gervais, Julie Paquette, Céline Morissette, Neurobiology of Aging Neurodegenerative DiseasesMedicinePeptide EngineeringPeptide TherapeuticSoluble Aβ Peptide	2006	301
Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain David L. Brody, Sandra Magnoni, Kate E. Schwetye, Science	2008	289
Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry–mass spectrometry Lydia Young, Janet C. Saunders, Rachel Mahood, Nature Chemistry BiochemistryNatural SciencesMedicineMass SpectrometryBiological Mass Spectrometry	2014	282
Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study) Paul Aisen, Serge Gauthier, Steven H. Ferris, Archives of Medical Science	2011	277
Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide Tadafumi Hashimoto, Alberto Serrano‐Pozo, Yukiko Hori, Journal of Neuroscience	2012	273
A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease Paul Aisen, Daniel Saumier, Richard Briand, Neurology	2006	199

Page 1